KDIGO AKI Staging

ورودی‌های بالینی بیمار

حداقل ۰.۲ — حداکثر ۱۵ • واحد: mg/dL

حداقل ۰.۲ — حداکثر ۲۰ • واحد: mg/dL

حداقل ۰ — حداکثر ۱۰ • واحد: mg/dL

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
aki stage
—stage
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • No AKI0–0
  • Stage 11–1
  • Stage 22–2
  • Stage 33–3
Direct Clinical Answer

The KDIGO AKI Staging calculates estimating glomerular filtration rate (eGFR), staging renal disease, and adjusting drug clearances. Key inputs include baseline scr. Scores guide adjusting renal medication clearance, coordinating nephrology follow-up, or planning renal replacement therapy. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

KDIGO acute kidney injury staging (2012) from serum creatinine change and urine output: Stage 1 (SCr 1.5-1.9× baseline or ≥0.3 mg/dL rise; UO <0.5 mL/kg/h for 6-12 h), Stage 2 (SCr 2.0-2.9×; UO <0.5 for ≥12 h), Stage 3 (SCr 3.0× or ≥4.0 mg/dL or RRT; UO <0.3 for ≥24 h or anuria ≥12 h). Stage = worst of the creatinine and urine-output criteria.

Clinical Indication

The KDIGO AKI Staging is indicated for bedside clinical practice to support KDIGO acute kidney injury staging (2012) from serum creatinine change and urine output: Stage 1 (SCr 1.5-1.9× baseline or ≥0.3 mg/dL rise; UO <0.5 mL/kg/h for 6-12 h), Stage 2 (SCr 2.0-2.9×; UO <0.5 for ≥12 h), Stage 3 (SCr 3.0× or ≥4.0 mg/dL or RRT; UO <0.3 for ≥24 h or anuria ≥12 h). Stage = worst of the creatinine and urine-output criteria.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with acute kidney injury (AKI), chronic kidney disease stages 1-5, or acid-base and fluid-electrolyte disturbances. Clinical application is indicated across Nephrology clinics, hemodialysis units, acute inpatient renal services, and metabolic wards.

Limitations & Contraindications

eGFR estimation equations assume steady-state serum creatinine and become unreliable during unstable AKI, amputations, or extremes of muscle mass.

Clinical Pearls & Action Plan

Serum creatinine lags behind acute reductions in glomerular filtration; monitor hourly urine output and consider cystatin C in evolving AKI.

Formula & Variables:

Stage = max(creatinine stage, urine-output stage) per KDIGO thresholds

Input Parameters

NameTypeRequiredDescription
baseline_scrfloatYesBaseline serum creatinine(mg/dL)
current_scrfloatYesCurrent serum creatinine(mg/dL)
rise_48hfloatNoAbsolute rise within 48 h (optional; ≥0.3 qualifies Stage 1)(mg/dL)
uo_categorystringNoLowest qualifying urine-output category observed
on_rrtstringNoRenal replacement therapy initiated

Score Interpretation & Guidance

RangeStageDescription
0–0No AKINo AKI
1–1Stage 1Stage 1
2–2Stage 2Stage 2
3–3Stage 3Stage 3

Evidence-Based References (EBM)

  • Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1-138.

Related calculators